🔎 Trials Near Me

መነሻ › ቫይረሳዊ ኢንፌክሽኖች › ዲስትሪክት ኦፍ ኮሎምቢያ › Washington

በWashington፣ DC ለቫይረሳዊ ኢንፌክሽኖች የሚደረጉ ክሊኒካዊ ጥናቶች

ለቫይረሳዊ ኢንፌክሽኖች የሚደረጉ 12 ጥናቶች በWashington እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Washington D.C.
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05624450

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT00006518

The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ2 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT01011712

Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection

ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ18 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07706686

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Georgetown University Medical Center, Washington D.C.
  • Jadestone Clinical Research, Silver Spring · 7 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07013474

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Georgetown University Medical Center, Washington D.C.
  • Emerson Clinical Research Institute, Washington D.C.
  • Jadestone Clinical Research, Silver Spring · 7 ማይል ርቀት
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06679140

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
  • George Washington University, Washington D.C.
እድሜ ከ18 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07565090

Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

ተሳታዮችን በመፈለግ ላይደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ18 እስከ 50 · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06863142

Viral Infections in Healthy and Immunocompromised Hosts

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
6 Months – 120 Years · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT01306084

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
2 Months – 115 Years · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT04419870

Genetic Studies of Chronic Active Epstein-Barr Disease

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • National Institutes of Health Clinical Center, Bethesda · 7 ማይል ርቀት
እድሜ ከ1 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ28 ጁላይ 2026 · NCT00032513

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Children's National Hospital, Washington D.C.
  • National Institutes of Health (NIH), Bethesda · 7 ማይል ርቀት
3 Months – 80 Years · ሁሉም ጾታዎች · የተሻሻለው በ26 ጃንዩ 2026 · NCT04691622

በሌሎች ከተሞች ለቫይረሳዊ ኢንፌክሽኖች የሚደረጉ ጥናቶች

በWashington ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።